Consolidated Portfolio Review Corp »

AstraZeneca shares owned by Consolidated Portfolio Review Corp

Quarter-by-quarter ownership of AstraZeneca (AZN) shares owned by Consolidated Portfolio Review Corp from 13F filings

Historical chart of Consolidated Portfolio Review Corp investment in AstraZeneca

Tip: Access up to 7 years of quarterly data

All positions including AstraZeneca held by Consolidated Portfolio Review Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AstraZeneca by Consolidated Portfolio Review Corp

Quarter filed Position value Share count Share price at filing
2025-09-30 $360k 4.7k 76.71
2025-06-30 $331k 4.7k 69.89
2025-03-31 $348k 4.7k 73.51
2024-12-31 $343k 5.2k 65.52

More positions owned by Consolidated Portfolio Review Corp

Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Bd Index Fds Intermed Term (BIV)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds Value Etf (VTV)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Strategy Cl A New (MSTR)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Invesco Exchange Traded Fd T S&p 500 Top 50 (XLG)
NVIDIA Corporation (NVDA)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Amazon (AMZN)
Vanguard World Health Car Etf (VHT)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)

View all positions for Consolidated Portfolio Review Corp

Top funds holding AstraZeneca

PRIMECAP Management Company
Wellington Management Company
Capital Research and Management Company - Division 3
FMR
Fisher Investments
Franklin Resources
Sanders Capital
Goldman Sachs Group
Morgan Stanley
Atlantic Trust
Dimensional Fund Advisors
Holocene Advisors
BlackRock
Ameriprise Financial
Robeco Investment Management

View all funds holding AstraZeneca